Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. 

CEO
Christophe Weber
CEOChristophe Weber
Employees
47,455
Employees47,455
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,455
Employees47,455

TAK Key Statistics

Market cap
52.45B
Market cap52.45B
Price-Earnings ratio
70.82
Price-Earnings ratio70.82
Dividend yield
3.40%
Dividend yield3.40%
Average volume
3.02M
Average volume3.02M
High today
$16.88
High today$16.88
Low today
$16.59
Low today$16.59
Open price
$16.72
Open price$16.72
Volume
2.87M
Volume2.87M
52 Week high
$18.90
52 Week high$18.90
52 Week low
$12.99
52 Week low$12.99

TAK News

Simply Wall St 6d
Why Denali Therapeutics Is Up 7.4% After Regaining Full Rights To DNL593 Collaboration

On April 3, 2026, Takeda Pharmaceutical notified Denali Therapeutics that it will terminate their 2018 collaboration to co-develop and co-commercialize DNL593 (...

Why Denali Therapeutics Is Up 7.4% After Regaining Full Rights To DNL593 Collaboration
TipRanks 6d
Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...

TipRanks 6d
Takeda’s Real-World Dengue Vaccine Study Could Reshape Its Emerging Markets Outlook

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...

Analyst ratings

60%

of 15 ratings
Buy
60%
Hold
33.3%
Sell
6.7%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.